PHARMACOTHERAPY OF ANALGESIA, SEDATION AND NEUROMUSCULAR BLOCKADE IN CRITICALLY ILL PATIENTS WITH PULMONARY DISEASES

Authors

  • Pawanrat Svetsomboon Clinical Pharmacy Section, Pharmacy Division, Ramathibodi Hospital, Bangkok
  • Kanokrada Thammasri Clinical Pharmacy Section, Pharmacy Division, Ramathibodi Hospital, Bangkok
  • Vichapat Tharanon Clinical Pharmacy Section, Pharmacy Division, Ramathibodi Hospital, Bangkok
  • Tananchai Petnak Pulmonary and Critical Care Unit, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok
  • Yuda Sutherasan Pulmonary and Critical Care Unit, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok

DOI:

https://doi.org/10.69598/tbps.19.1.95-116

Keywords:

analgesia, sedation, neuromuscular blocking agents, critically ill patient, acute respiratory distress syndrome

Abstract

Critically ill patients with pulmonary disease who are admitted to the intensive care unit (ICU) generally experience procedural pain caused by life-saving treatment. Patients who receive ineffective pain treatment may frequently suffer from anxiety, agitation, or delirium. When the patients have already experienced these adverse conditions, the length of the mechanical ventilator and ICU stay might increase accordingly. Furthermore, patients with acute respiratory distress syndrome (ARDS) usually require deep sedation and a temporary paralysis state; therefore, analgesics, sedatives, and neuromuscular blocking agents are necessarily indicated in order to achieve the treatment. For critically ill patients to obtain the most effective and safe treatment with analgesics, sedatives, antipsychotics, and neuromuscular blocking agents administered, critical care pharmacists who provide pharmaceutical care to patients should have fundamental knowledge and be able to apply pragmatic pharmacotherapy, pharmacokinetics, and pharmacodynamics knowledge to optimize and personalize these medications for ARDS patients because they are high alert drugs with high adverse effects, aiming to provide patients with medicines that are effective, safe, and able to overcome crises.

References

Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788–800.

Temesgen N, Chekol B, Tamirie T, Eshetie D, Simeneh N, Feleke A. Adult sedation and analgesia in a resource limited intensive care unit - A systematic review and evidence based guideline. Ann Med Surg (Lond). 2021;66:102356.

Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med. 2014;370(5):444-54.

Seo Y, Lee HJ, Ha EJ, Ha TS. 2021 KSCCM clinical practice guidelines for pain, agitation, delirium, immobility, and sleep disturbance in the intensive care unit. Acute Crit Care. 2022;37(1):1-25.

Chanques G, Drouot X, Payen JF. 2008–2018: Ten years of gradual changes in the sedation guidelines for critically ill patients. Anaesth Crit Care Pain Med. 2018;37(6):509-11.

Gélinas C. Pain assessment in the critically ill adult: Recent evidence and new trends. Intensive Crit Care Nurs. 2016; 34:1-11.

The Royal College of Anesthesiologists of Thailand and Thai Association for the Study of Pain. Clinical guidance for acute postoperative pain management 2nd ed. Bangkok: Thai Association for the Study of Pain; 2019. (in Thai)

Wongtangman K, Chaiwat O, Suraseranivongse S, Thikom N, Sanansilp V, Wangnamthip S. Validation of the Thai version critical care pain observation tool and behavioral pain scale in postoperative mechanically ventilated ICU Patients. J Med Assoc Thai. 2017;100(Suppl 7):S9-19.

Chanques G, Payen JF, Mercier G, de Lattre S, Viel E, Jung B, et al. Assessing pain in non-intubated critically ill patients unable to self-report: An adaptation of the behavioral pain scale. Intensive Care Med. 2009;35(12):2060-7.

Kerson AG, DeMaria R, Mauer E, Joyce C, Gerber LM, Greenwald BM, et al. Validity of the Richmond Agitation-Sedation Scale (RASS) in critically ill children. J Intensive Care. 2016;4:65.

Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O’Neal PV, Keane KA, et al. The Richmond agitation-sedation scale: Validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338-44.

Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Executive summary: Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825-73.

Bourenne J, Hraiech S, Roch A, Gainnier M, Papazian L, Forel JM. Sedation and neuromuscular blocking agents in acute respiratory distress syndrome. Ann Transl Med. 2017;5(14):291.

Pappal RD, Roberts BW, Winkler W, Yaegar LH, Stephens RJ, Fuller BM. Awareness and bispectral index (BIS) monitoring in mechanically ventilated patients in the emergency department and intensive care unit: A systematic review protocol. BMJ Open. 2020;10:e034673.

Ho ATN, Patolia S, Guervilly C. Neuromuscular blockade in acute respiratory distress syndrome: A systematic review and meta-analysis of randomized controlled trials. J Intensive Care. 2020;8(3):12.

Murray MJ, DeBlock H, Erstad B, Gray A, Jacobi J, Jordan C, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med. 2016;44(11):2079-103.

Heavner, MS, Gorman, EF, Linn, DD, Yeung, SYA, Miano, TA. Systematic review and meta-analysis of the correlation between bispectral index (BIS) and clinical sedation scales: Toward defining the role of BIS in critically ill patient. Pharamacotherapy. 2022;42(8):667-76.

Devlin JW, Skrobik Y, Gelinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825-73.

Vincent JL, Shehabi Y, Walsh TS, Pandharipande PP, Ball JA, Spronk P, et al. Comfort and patient-centred care without excessive sedation: The eCASH concept. Intensive Care Med. 2016;42(6):962–71.

Mehta S, Spies C, Shehabi Y. Ten tips for ICU sedation. Intensive Care Med. 2018;44(7):1141–3.

Young C, Knudsen N, Hilton A, Reves JG. Sedation in the intensive care unit. Crit Care Med. 2000;28:854–66.

UpToDate [Database on the internet]. Waltham: Wolters Kluwer Clinical Drug Information; Sedative-analgesic medications in critically ill adults: Selection, initiation, maintenance, and withdrawal [cited 2023 Jul 6]. Available from: https://www.uptodate.com [Subscription required to view].

Grotberg JC, Reynolds D, Kraft BD. Management of severe acute respiratory distress syndrome: a primer. Crit Care. 2023;27(1):289.

Chanques G, Constantin JM, Devlin JW, Ely EW, Fraser GL, Gélinas C, et al. Analgesia and sedation in patients with ARDS. Intensive Care Med. 2020;46(12):2342-56.

Shehabi Y, Al-Bassam W, Pakavakis A, Murfin B, Howe B. Optimal sedation and pain management: A patient- and symptom-oriented paradigm. Semin Respir Crit Care Med. 2021;42(1):98-111.

Murray MJ, DeBlock H, Erstad B, Gray A, Jacobi J, Jordan C, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med. 2016;44:2079-103.

Daou M, Telias I, Younes M, Brochard L, Wilcox ME. Abnormal sleep, circadian rhythm disruption, and delirium in the ICU: Are they related? Front Neurol. 2020;11:549908.

Pipanmekaporn T, Wongpakaran N, Mueankwan S, Dendumrongkul P, Chittawatanarat K, Khongpheng N, et al. Validity and reliability of the Thai version of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Clin Interv Aging. 2014;9:879-85.

Sottile PD, Kiser TH, Burnham EL, Ho PM, Allen RR, Vandivier RW, et al. An observational study of the efficacy of cisatracurium compared with vecuronium in patients with or at risk for acute respiratory distress syndrome. Am J Respir Crit Care Med. 2018;197(7):897-904.

Warr J, Thiboutot Z, Rose L, Mehta S, Burry LD. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults. Ann Pharmacother. 2011;45(9):1116-26.

Topolovec-Vranic J, Gélinas C, Li Y, Pollmann-Mudryj MA, Innis J, McFarlan BAA, et al.Validation and evaluation of two observational pain assessment tools in a trauma and neurosurgical intensive care unit. Pain Res Manag. 2013;18(6):e107-14.

Murray MJ, DeBlock HF, Erstad BL, Gray AW Jr, Jacobi J, Jordan CJ, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient: 2016 Update-executive summary. Am J Health Syst Pharm. 2017;74(2):76–8.

Baumann MH, McAlpin BW, Brown K, Patel P, Ahmad I, Stewart R, et al. A prospective randomized comparison of train-of-four monitoring and clinical assessment during continuous ICU cisatracurium paralysis. Chest. 2004;126(4):1267-73.

Murray MJ, DeBlock H, Erstad B, Gray A, Jacobi J, Jordan C, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med. 2016;44(11):2079-103.

Downloads

Published

2023-11-06

How to Cite

Svetsomboon, P. ., Thammasri, K. ., Tharanon, V., Petnak, T. ., & Sutherasan, Y. (2023). PHARMACOTHERAPY OF ANALGESIA, SEDATION AND NEUROMUSCULAR BLOCKADE IN CRITICALLY ILL PATIENTS WITH PULMONARY DISEASES. Thai Bulletin of Pharmaceutical Sciences, 19(1), 95–116. https://doi.org/10.69598/tbps.19.1.95-116

Issue

Section

Review Articles